MAGEB10 and Charcot-Marie-Tooth disease: These findings suggest that DNA hypomethylation may drive the expression of MAGE-B1, MAGE-B4, MAGE-B5, and MAGE-B10 mRNA in primary benign and malignant CMT cells.